GENEVA, Switzerland—Alcon (SIX/NYSE: ALC) announced a series of updates yesterday stemming from the impact of COVID-19, among them the withdrawal of its full year 2020 guidance previously disclosed on Feb. 25. The company noted, "Most countries and local municipalities have mandated or advised unprecedented measures to help contain the spread of COVID-19. These measures, which have necessitated a temporary deferral of eyecare procedures and exams in many markets, are anticipated to have an impact on Alcon’s financial results.

Read more